Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales
Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements
Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results Business Updates
Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.